-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
March 01, 2016 - individuals, a
high proportion of whom have comorbidities or are at
risk for comorbidities such as hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_research-protocol.pdf
June 05, 2014 - diabetes-related complications
included smoking (20 percent), self-reported overweight or obesity (86 percent), hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
June 15, 2016 - it coexists with pathological
conditions such as cardiac and respiratory
diseases, diabetes, or hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-disposition.pdf
June 22, 2017 - References are cited for pulmonary
embolus management [10],
thromboembolic pulmonary hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
March 01, 2009 - points), at least 70 years old (2 points), diabetes mellitus (3 points), cigarette smoking (1 point), hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
June 01, 2015 - type 2 diabetes mellitus
(T2DM), coronary artery disease, dyslipidemia, cardiometabolic syndrome, hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/smoking-pregnancy-infants_research-protocol.pdf
March 11, 2013 - Smoking is associated with increased risk of placental abruption, anemia, preterm birth, chronic
hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
September 01, 2010 - effects of raloxifene, a selective
estrogen receptor modulator, on
monocrotaline-induced pulmonary
hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
May 01, 2012 - #106 is Effect of Vitamin D Replacement During Winter Months in Patients With Hypertension
#107 is
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
February 01, 2024 - Making Healthcare Safer IV_Rapid Response_Deprescribing To Reduce Medication Harms in Older Adults
Making Healthcare Safer IV
Deprescribing To Reduce Medication
Harms in Older Adults
Rapid Response
Main Points
• Deprescribing has emerged as a clinical practice to reduce polypharmacy and
use of potenti…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-creating-efficiencies-extraction-data.pdf
August 01, 2021 - Milrinone pharmacokinetics and
pharmacodynamics in neonates with persistent pulmonary hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research.pdf
July 01, 2012 - High blood pressure YES NO
e. High/abnormal Cholesterol YES NO
f. … Other:
Medical History (check where applicable):
□ Anemia □ Dermatophytosis □ Hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
August 01, 2013 - population that is disproportionately affected by a condition and
known to have poor health outcomes (e.g., hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-chronic-kidney-rapid-research.pdf
November 01, 2024 - Other causes of CKD include hypertension, heart disease, primary glomerular
diseases, genetic diseases … a buildup of excess fluid and
toxic waste, which in turn causes other health complications such as high … blood pressure, heart disease,
and stroke.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
October 25, 2010 - effects of raloxifene, a selective
estrogen receptor modulator, on
monocrotaline-induced pulmonary
hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
September 01, 2013 - Across studies, the median
proportions of patients with dyslipidemia and hypertension
were both over … the distribution of
risk factors for ischemic vascular disease (male sex,
hyperlipidemia, diabetes, hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
April 01, 2021 - , we
concluded that "data were
very limited on the efficacy
for conditions other than
resistant hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_executive.pdf
January 01, 2014 - Conclusions
Chronic wounds due to venous hypertension are emerging
as a major clinical care and public
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
November 01, 2024 - diabetes.3 These inflammatory exacerbating factors are now thought to include
atherosclerosis, obesity, hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
December 01, 2011 - that is disproportionately affected by a condition and known to have poor health outcomes (e.g.,
hypertension